2009 DDP Sponsors
IIR recognizes the contributions of these Sponsors.
If you would like to learn more about sponsorship opportunities with us, click here.
Gold Sponsors
Bend Research Inc. specializes in the research and development of novel pharmaceutical-delivery technologies. The company is vertically integrated, with activities ranging from fundamental research to the design and scale-up of pharmaceutical processes to manufacture of clinical supplies. The company employs more than 140 people.http://www.bendresearch.com
DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR™, and TRANSDUR™-Sufentanil. DURECT’s proprietary (oral, transdermal and injectable depot) delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visithttp://www.durect.com
Elan provides a broad range of creative product optimization approaches to clients including formulation development, scale-up and manufacturing. Technologies include NanoCrystal® Technology to enhance dissolution of poorly soluble drugs which can be incorporated into a variety of dosage forms and Controlled Release technologies which customize release profiles for range oral dosage forms.http://www.elan.com/EDT
Eurand is a global specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has a strong track record of developing products using its innovative drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has four primary technology platforms:http://www.eurand.com- Customized Drug Release
- Bioavailability Enhancement
- Taste Masking / Orally Disintegrating Tablets (ODTs)
- Drug Conjugation
.jpg "Davidson, Davidson and Kappel")
Davidson, Davidson and Kappel
Davidson, Davidson & Kappel, LLC is a full-service intellectual property law firm with offices in New York City. The firm has a particularly strong emphasis in the pharmaceutical arts. Attorneys at DDK have written highly valuable pharmaceutical patents, and have litigated and opined on others. At DDK, we pride ourselves on our ability to provide prompt, personal attention to our clients’ intellectual property matters. The protection of intellectual property assets is a critical factor in the success of any technology-oriented business. Our firm provides the counseling and representation necessary to protect the U.S. and international assets of our clients, including patent and trademark procurement, clearance and infringement counseling and analysis; pharmaceutical life cycle management, intellectual property due diligence and transactional counseling; intellectual property licensing; and intellectual property litigation (including Hatch-Waxman). The firm is known for its cutting-edge abilities in drafting patents/patent claims covering pharmaceuticals and biologicals.
Silver Sponsors
3M Drug Delivery Systems partners with pharmaceutical and biotech companies to team your molecules with our inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with global regulatory expertise and guidance. This depth of resources is one reason why more than 50% of all metered-dose inhalers worldwide and 80% of all transdermal systems in the U.S. utilize 3M drug delivery technology.http://www.mmm.com
Altea Therapeutics is a private specialty pharmaceutical company developing and commercializing pharmaceutical products based on a new class of transdermal patches that deliver therapeutic levels of water-soluble small drugs, proteins and carbohydrates in a convenient, painless and cost-effective manner.http://www.alteatherapeutics.com
Aveva Drug Delivery Systems offers a full range of Transdermal patch products for license along with a full compliment of R&D capabilities to produce transdermal drug delivery systems that fortify R&D pipelines and maximize product life cycles. Aveva is one of the world’s largest manufacturers of, and a pioneer in, transdermal drug delivery systems with a 20-year history of providing value to pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs.http://www.avevadds.com
Associate Sponsor
http://www.banpharm.comBanner is a global gelatin-based drug delivery and specialty pharmaceutical company. We are committed to researching, developing and producing unique oral dosage forms for the Pharmaceutical Health Care Industry. Through our innovative technologies and products, and with the dedication of our employees, we seek to improve the quality of life for our global community.
As a world leader in developing innovative drug delivery systems and patented technologies, Banner offers breakthrough technologies such as Soflet® Gelcaps, Chewels™ chewable gels, LiquiSoft, chewable liquid filled softgels, EnteriCare™ enteric softgels, Versatrol™ controlled release softgels, and EcoCaps™ non-animal softgels.
Brookwood - Genzyme Pharmaceuticals Collaboration
Brookwood Pharmaceuticals
Brookwood Pharmaceuticals, Inc., a SurModics company – a drug delivery company focused on product development, manufacturing and biomaterials. Technologies: Long-acting parenterals (microparticles, nanoparticles, and injectable solid implants), Systemic and Local Delivery (small molecules, peptides, proteins, antibodies and nucleic acids), Design for Peptide DeliverySM www.d4pd.com, NLCsTM (Nanostructured Lipid Carriers), Lakeshore BiomaterialsTM (in-stock and custom biodegradable polymers). Services: Partnered programs (feasibility studies, product development and optimization), process scale up and engineering, Clinical trial and commercial manufacturing.Genzyme Pharmaceuticals
Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, is an integrated resource of value-added technologies, custom manufacturing and strategic relationships focused in the lipid, peptide, amino acid derivative and drug delivery markets, including oligonucleotide delivery. Technologies: LipoBridge® LipoMaskTM, CerenseSM Design for Peptide DeliverySM www.d4pd.com. Services: Custom Manufacturing – API’s, complex organics, intermediates.
Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. We apply our local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Stop by our booth!http://www.catalent.com
Throughout its 22-year history, LTS has been a world class developer and manufacturer of innovative transdermal/oral delivery systems and cosmetics/ environmental care products. State-of-the-art laboratory and manufacturing facilities are located in Germany and the US. The headcount of 900 people comprises 100 researchers for product development from feasibility through manufacturing (including clinical evaluation).http://www.ltslohmann.com/
http://www.pantec-biosolutions.comInjection free intraepidermal drug delivery.
Pantec Biosolutions AG develops and commercialises a laser-powered skin microporation method (P.L.E.A.S.E.® - Painless laser epidermal system) prior to drug patch application, which extends the range of drugs that can be delivered transdermally to large molecular weight drugs. This novel application allows delivering the drugs directly into the epidermis in a dose controlled way, avoiding painful injections.
The company's first focus is to replace around hundred injections applied during hormone therapy in In Vitro Fertilisation (IVF).
Drug patch development for IVF hormones is underway, and the company will commercialise the product solution "P.L.E.A.S.E.® - device plus drug patches" with a Pharma partner company. Further interesting therapeutic areas are in preclinical development.
Zosano Pharma ™, Inc. is a privately held pharmaceutical company developing a novel transdermal delivery technology for a broad range of therapeutic indications. Its lead clinical program, the ZP-PTH rapid delivery patch for the treatment of osteoporosis, is being developed as an alternative to daily injections. Zosano’s transdermal delivery technology is capable of delivering peptides, proteins, small molecules and vaccines by permeating the skin’s outer layer and ensuring significant therapeutic effect. A fully integrated development company, Zosano has a cGMP manufacturing facility that can deliver Phase 3 supplies and additional pipeline products. Zosano aims to develop products both independently and through strategic licensing and co-development arrangements. Founded in 2006 as an ALZA/Johnson & Johnson spin-out led by Nomura Phase4 Ventures, Zosano has raised $90 million in series B funding from New Enterprise Associates, Nomura Phase4 Ventures, HBM BioVentures and ProQuest Investments. Zosano is located in Fremont, CA. For more information, please visithttp://www.zosanopharma.com